Aashirya Drugs Private Limited
About Aashirya Drugs Private Limited
Data last updated:
Aashirya Drugs Private Limited is a private limited company based in Gorakhpur, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24299UP2018PTC101026.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7 Lakh. It is led by directors Shubhanshu Kumar Shah and Prabha Devi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Sunil Agarwal Mahewa Rustampur, Gorakhpur, Uttar Pradesh, India – 273001.
Company details
Contact details
Aashirya Drugs Private Limited's registered office is in Gorakhpur, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Sunil Agarwal Mahewa Rustampur, Gorakhpur, Uttar Pradesh, India – 273001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Aashirya Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Aashirya Drugs Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aashirya Drugs Private Limited, buy the company report.
Board of directors of Aashirya Drugs Private Limited
Aashirya Drugs has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shubhanshu Kumar Shah | Director | 16 Feb 2018 | 8 Years 8 Months | Current |
| Prabha Devi | Additional Director | 18 Aug 2025 | 1 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving Aashirya Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aashirya Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Aashirya Drugs Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Aashirya Drugs Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Amit Kumar Mishra ceased to be Director on 19 Aug 2025.
Frequently asked questions
Aashirya Drugs is an active private limited company based in Gorakhpur, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 February 2018 (8+ years old) and is registered under CIN U24299UP2018PTC101026.
Aashirya Drugs has 2 current directors:
- Shubhanshu Kumar Shah - Director
- Prabha Devi - Additional Director
The latest financial statements of Aashirya Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The CIN (Corporate Identification Number) of Aashirya Drugs is U24299UP2018PTC101026. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aashirya Drugs was incorporated on 16 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Kanpur.
Amit Kumar Mishra ceased to be Director on 19 Aug 2025. Prabha Devi was appointed as Additional Director on 18 Aug 2025. Shubhanshu Kumar Shah was appointed as Director on 16 Feb 2018.
The registered office of Aashirya Drugs is at CO Sunil Agarwal Mahewa Rustampur, Gorakhpur, Uttar Pradesh, India – 273001.
Aashirya Drugs operates in the pharma industry, in the drug formulation and development segment.
Aashirya Drugs can be reached at its registered office: CO Sunil Agarwal Mahewa Rustampur, Gorakhpur, Uttar Pradesh, India – 273001.
Aashirya Drugs is registered under the jurisdiction of the Registrar of Companies (ROC), Kanpur.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
